CAI — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

9.59

Margin Of Safety %

-31

Put/Call OI Ratio

0.57

EPS Next Q Diff

EPS Last/This Y

3.35

EPS This/Next Y

0.23

Price

22.74

Target Price

26.75

Analyst Recom

1.54

Performance Q

14.62

Upside

-43.1%

Beta

0.92

Ticker: CAI

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-13	CAI	17.06	0.46	0.15	11904
2026-07-14	CAI	16.93	0.46	0.09	11920
2026-07-15	CAI	17.48	0.46	0.02	11878
2026-07-16	CAI	16.47	0.47	0.26	11816
2026-07-17	CAI	16.49	0.43	0.73	11544
2026-07-20	CAI	15.55	0.46	0.25	8709
2026-07-21	CAI	15.73	0.44	0.37	9448
2026-07-22	CAI	15.38	0.44	5.63	9529
2026-07-23	CAI	15.65	0.44	7.80	9549
2026-07-24	CAI	15.53	0.45	0.53	9603
2026-07-27	CAI	15.62	0.45	0.08	9682
2026-07-28	CAI	15.59	0.45	1.70	9689
2026-07-29	CAI	15.59	0.45	0.39	9685
2026-07-30	CAI	16.11	0.44	0.06	9757
2026-07-31	CAI	15.66	0.43	0.90	9920
2026-08-03	CAI	16.32	0.45	0.03	10370
2026-08-04	CAI	16.09	0.44	0.40	10515
2026-08-05	CAI	16.46	0.44	0.91	10631
2026-08-06	CAI	19.97	0.57	0.12	15924
2026-08-07	CAI	22.74	0.57	0.03	16232
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-13	CAI	17.07	101.0	-21.8	0.13
2026-07-14	CAI	16.94	101.0	-22.7	0.13
2026-07-15	CAI	17.48	101.0	-19.7	0.13
2026-07-16	CAI	16.48	101.0	-26.4	0.13
2026-07-17	CAI	16.48	101.0	-22.0	0.13
2026-07-20	CAI	15.56	101.0	-26.3	0.13
2026-07-21	CAI	15.74	101.0	-21.3	0.13
2026-07-22	CAI	15.38	101.0	-23.8	0.13
2026-07-23	CAI	15.65	101.0	-20.8	0.13
2026-07-24	CAI	15.52	101.2	-22.8	0.13
2026-07-27	CAI	15.62	101.2	-21.7	0.13
2026-07-28	CAI	15.60	101.2	-22.3	0.13
2026-07-29	CAI	15.58	101.2	-22.2	0.13
2026-07-30	CAI	16.11	101.2	-19.6	0.13
2026-07-31	CAI	15.65	101.2	-24.2	0.13
2026-08-03	CAI	16.32	101.2	-19.0	0.13
2026-08-04	CAI	16.32	101.2	-19.0	0.13
2026-08-05	CAI	16.46	101.2	-20.4	0.13
2026-08-06	CAI	20.00	101.2	-6.0	0.13
2026-08-07	CAI	22.74	101.2	-73.3	0.13
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-13	CAI	0.06	15.71	11.58
2026-07-14	CAI	0.06	15.71	11.58
2026-07-15	CAI	0.06	15.71	11.58
2026-07-16	CAI	0.06	15.71	11.58
2026-07-17	CAI	0.06	15.71	11.58
2026-07-20	CAI	0.06	15.87	11.59
2026-07-21	CAI	0.06	15.87	11.59
2026-07-22	CAI	0.06	15.87	11.59
2026-07-23	CAI	0.06	15.87	11.59
2026-07-24	CAI	0.06	15.87	11.59
2026-07-27	CAI	0.06	16.99	9.59
2026-07-28	CAI	0.06	16.99	9.59
2026-07-29	CAI	0.06	16.99	9.59
2026-07-30	CAI	0.06	16.99	9.59
2026-07-31	CAI	0.06	16.99	9.59
2026-08-03	CAI	0.06	18.54	9.59
2026-08-04	CAI	0.06	18.54	9.59
2026-08-05	CAI	0.06	18.54	9.59
2026-08-06	CAI	0.06	18.54	9.59
2026-08-07	CAI	0.06	18.54	9.59
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

0.01

Avg. EPS Est. Next Quarter

0.04

Insider Transactions

0.06

Institutional Transactions

18.54

Beta

0.92

Average Sales Estimate Current Quarter

238

Average Sales Estimate Next Quarter

261

Fair Value

15.76

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

46.5

Max Drawdown 5-Year %

Target Price

26.75

P/E

61.08

Forward P/E

63.56

PEG

P/S

6.49

P/B

10.86

P/Free Cash Flow

55.28

EPS

0.37

Average EPS Est. Cur. Y

0.13

EPS Next Y. (Est.)

0.36

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

10.62

Relative Volume

2.6

Return on Equity vs Sector %

-9.6

Return on Equity vs Industry %

6.5

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

-73.3

◆ CAI Healthcare

$22.74

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

20/20

Pullback

2/25

Volume

0/15

Valuation

13/20

TP/AR

1/10

Options

6/10

RSI

78.6

Range 1M

99.6%

Sup Dist

18.2%

🚀

Momentum Growth

Ride accelerating trends

WATCH

Momentum

21/25

Growth

24/30

Estimates

3/20

Inst/Vol

10/15

Options

9/10

EPS Yr

128.1%

EPS NY

212.4%

52W%

28.9%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🔴 SELL -28% upside

Quality

20/30

Valuation

1/30

Growth

17/25

Stability

5/10

LT Trend

5/5

Upside

-28%

Quality

MoS

-31%

CAI — P/E HistoricalBiotechnology

Caris Life Sciences, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 1846

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms. The company's molecular intelligence product portfolio includes MI Profile Platform, a whole exome sequencing (WES)/ whole transcriptome sequencing (WTS) tissue-based molecular profiling solutions; Caris Assure Platform WES/WTS blood-based molecular profiling solutions; Precision Whole Genome Platform, a whole genome sequencing (WGS) blood- and tissue-based profiling solutions; and Caris Detect, a WGS-based multi-cancer early detection solution; Caris WGS MRD a WGS and digital droplet polymerase reaction-based minimal residual disease solution; and Caris ChromoSeq, a WGS and WTS based assay for therapy selection in hematological cancers. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company provides its precision oncology solutions to customers, such as hospitals, institutions and patients. The company was founded in 2008 and is headquartered in Irving, Texas.

CAI

Latest News

—

Caricamento notizie per CAI…

stock quote shares CAI – Caris Life Sciences Inc Stock Price stock today

news today CAI – Caris Life Sciences Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch CAI – Caris Life Sciences Inc yahoo finance google finance

stock history CAI – Caris Life Sciences Inc invest stock market

stock prices CAI premarket after hours

ticker CAI fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: CAI

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y